AXA S.A. - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 85 filers reported holding OVID THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 6.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
AXA S.A. ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$1,433,000
-58.0%
620,402
+4.3%
0.00%
-66.7%
Q3 2020$3,413,000
-67.4%
594,667
-58.1%
0.01%
-42.9%
Q2 2020$10,464,000
+115.1%
1,419,900
-13.0%
0.02%
+75.0%
Q1 2020$4,864,000
-32.5%
1,632,144
-5.9%
0.01%
-20.0%
Q4 2019$7,202,0001,735,2040.02%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,006,185$12,860,0005.90%
GLOBEFLEX CAPITAL L P 2,794,834$8,972,0000.92%
BVF INC/IL 6,631,051$21,286,0000.77%
EcoR1 Capital, LLC 6,082,200$19,524,0000.62%
CHI Advisors LLC 400,000$1,284,0000.43%
Ikarian Capital, LLC 705,082$2,264,0000.34%
Artal Group S.A. 2,500,000$8,025,0000.22%
DCF Advisers, LLC 141,701$455,0000.18%
PLATINUM INVESTMENT MANAGEMENT LTD 766,901$2,462,0000.07%
ACADIAN ASSET MANAGEMENT LLC 2,040,084$6,543,0000.02%
View complete list of OVID THERAPEUTICS INC shareholders